| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.012 | 0.9 |